PROTAC ERalpha Degrader-13 is an orally active PROTAC molecule that efficiently and selectively degrades ERalpha (DC50 = 3.78 nM). PROTAC ERalpha Degrader-13 has the characteristics of strong anti proliferation (IC50 = 0.6 nM), induction of apoptosis, and overcoming drug resistance in MCF-7 cells. PROTAC ERalpha Degrader-13 has good safety and no significant organ toxicity. PROTAC ERalpha Degrader-13 can be used for cancer research[1].
Molecular Weight:
1018.63
Formula:
C55H61ClFN7O7S
Target:
Apoptosis,Estrogen Receptor/ERR,PROTACs
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
